ViiV Healthcare — Drug Prices & Medicare Spending
ViiV Healthcare manufactures 6 drugs tracked by Medicare Part D with total spending of $4.8B.
6
Drugs Tracked
$4.8B
Medicare Spending
$3,479.80
Avg Cost/Claim
100%
Have Generics
ViiV Healthcare Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Triumeq | Dolutegravir/Abacavir/Lamivudine | $3,580.00 | Yes |
| 2 | Dovato | Dolutegravir/Lamivudine | $2,910.00 | Yes |
| 3 | Juluca | Dolutegravir/Rilpivirine | $3,831.00 | Yes |
| 4 | Cabenuva | Cabotegravir/Rilpivirine | $6,593.00 | Yes |
| 5 | Tivicay | Dolutegravir | $2,452.00 | Yes |
| 6 | Rukobia | Fostemsavir | $6,833.00 | Yes |
Frequently Asked Questions
ViiV Healthcare manufactures 6 drugs tracked by Medicare Part D, with total annual spending of $4.8B.
Rukobia (Fostemsavir) is the most expensive at $6,833.00 per claim.
6 of 6 ViiV Healthcare drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.